+916.7%
FTNT vs BBIO
+136.7%
+780.1%
-38.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.8% | -0.1% | -1.7% | -1.7% |
| 7D | -0.1% | -3.2% | +3.1% | +0.2% |
| 30D | -3.0% | -13.6% | +10.6% | -1.5% |
| 3M | +7.6% | +7.2% | +0.4% | +6.6% |
| 6M | +87.0% | +1.5% | +85.5% | +86.0% |
| YTD | +96.5% | -5.3% | +101.8% | +96.3% |
| 1Y | +92.9% | +37.7% | +55.2% | +84.9% |
| 3Y | +139.8% | +153.9% | -14.1% | +109.9% |
| 5Y | +151.3% | +43.9% | +107.5% | +95.3% |
| All | +916.7% | +136.7% | +780.1% | +535.0% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling